BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arendt LM, Rudnick JA, Keller PJ, Kuperwasser C. Stroma in breast development and disease. Semin Cell Dev Biol 2010;21:11-8. [PMID: 19857593 DOI: 10.1016/j.semcdb.2009.10.003] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 Fernández-Nogueira P, Mancino M, Fuster G, Bragado P, Puig MP, Gascón P, Casado FJ, Carbó N. Breast Mammographic Density: Stromal Implications on Breast Cancer Detection and Therapy. J Clin Med 2020;9:E776. [PMID: 32178425 DOI: 10.3390/jcm9030776] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Barcus CE, Holt EC, Keely PJ, Eliceiri KW, Schuler LA. Dense collagen-I matrices enhance pro-tumorigenic estrogen-prolactin crosstalk in MCF-7 and T47D breast cancer cells. PLoS One 2015;10:e0116891. [PMID: 25607819 DOI: 10.1371/journal.pone.0116891] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
3 Su Y, Shankar K, Rahal O, Simmen RC. Bidirectional signaling of mammary epithelium and stroma: implications for breast cancer--preventive actions of dietary factors. J Nutr Biochem 2011;22:605-11. [PMID: 21292471 DOI: 10.1016/j.jnutbio.2010.09.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
4 Pfefferle AD, Darr DB, Calhoun BC, Mott KR, Rosen JM, Perou CM. The MMTV-Wnt1 murine model produces two phenotypically distinct subtypes of mammary tumors with unique therapeutic responses to an EGFR inhibitor. Dis Model Mech 2019;12:dmm037192. [PMID: 31213486 DOI: 10.1242/dmm.037192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
5 Qiao A, Gu F, Guo X, Zhang X, Fu L. Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications. Front Med 2016;10:33-40. [DOI: 10.1007/s11684-016-0431-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 7.0] [Reference Citation Analysis]
6 Al-Ansari MM, Hendrayani SF, Shehata AI, Aboussekhra A. p16(INK4A) represses the paracrine tumor-promoting effects of breast stromal fibroblasts. Oncogene 2013;32:2356-64. [PMID: 22751126 DOI: 10.1038/onc.2012.270] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 4.9] [Reference Citation Analysis]
7 Sun Y, Yang D, Xi L, Chen Y, Fu L, Sun K, Yin J, Li X, Liu S, Qin Y, Liu M, Hou Y. Primed atypical ductal hyperplasia-associated fibroblasts promote cell growth and polarity changes of transformed epithelium-like breast cancer MCF-7 cells via miR-200b/c-IKKβ signaling. Cell Death Dis 2018;9:122. [PMID: 29374150 DOI: 10.1038/s41419-017-0133-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
8 Lee K, Nelson CM. New insights into the regulation of epithelial-mesenchymal transition and tissue fibrosis. Int Rev Cell Mol Biol. 2012;294:171-221. [PMID: 22364874 DOI: 10.1016/B978-0-12-394305-7.00004-5] [Cited by in Crossref: 101] [Cited by in F6Publishing: 61] [Article Influence: 10.1] [Reference Citation Analysis]
9 Rohira AD, Lonard DM, O'Malley BW. Emerging roles of steroid receptor coactivators in stromal cell responses. J Endocrinol 2021;248:R41-50. [PMID: 33337343 DOI: 10.1530/JOE-20-0511] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Al-Rakan MA, Hendrayani SF, Aboussekhra A. CHEK2 represses breast stromal fibroblasts and their paracrine tumor-promoting effects through suppressing SDF-1 and IL-6. BMC Cancer 2016;16:575. [PMID: 27484185 DOI: 10.1186/s12885-016-2614-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
11 Fontelles CC, da Cruz RS, Gonsiewski AK, Barin E, Tekmen V, Jin L, Cruz MI, Loudig O, Warri A, de Assis S. Systemic alterations play a dominant role in epigenetic predisposition to breast cancer in offspring of obese fathers and is transmitted to a second generation. Sci Rep 2021;11:7317. [PMID: 33795711 DOI: 10.1038/s41598-021-86548-w] [Reference Citation Analysis]
12 Hilakivi-Clarke L, Andrade JE, Helferich W. Is soy consumption good or bad for the breast? J Nutr. 2010;140:2326S-2334S. [PMID: 20980638 DOI: 10.3945/jn.110.124230] [Cited by in Crossref: 81] [Cited by in F6Publishing: 56] [Article Influence: 6.8] [Reference Citation Analysis]
13 Fröhlich C, Nehammer C, Albrechtsen R, Kronqvist P, Kveiborg M, Sehara-Fujisawa A, Mercurio AM, Wewer UM. ADAM12 produced by tumor cells rather than stromal cells accelerates breast tumor progression. Mol Cancer Res 2011;9:1449-61. [PMID: 21875931 DOI: 10.1158/1541-7786.MCR-11-0100] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
14 McCave EJ, Cass CA, Burg KJ, Booth BW. The normal microenvironment directs mammary gland development. J Mammary Gland Biol Neoplasia 2010;15:291-9. [PMID: 20824492 DOI: 10.1007/s10911-010-9190-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
15 Wion D, Appaix F, Burruss M, Berger F, van der Sanden B. Cancer research in need of a scientific revolution: Using 'paradigm shift' as a method of investigation. J Biosci 2015;40:657-66. [PMID: 26333409 DOI: 10.1007/s12038-015-9543-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
16 Ren Y, Jia HH, Xu YQ, Zhou X, Zhao XH, Wang YF, Song X, Zhu ZY, Sun T, Dou Y, Tian WP, Zhao XL, Kang CS, Mei M. Paracrine and epigenetic control of CAF-induced metastasis: the role of HOTAIR stimulated by TGF-ß1 secretion. Mol Cancer 2018;17:5. [PMID: 29325547 DOI: 10.1186/s12943-018-0758-4] [Cited by in Crossref: 70] [Cited by in F6Publishing: 76] [Article Influence: 17.5] [Reference Citation Analysis]
17 Wronski A, Arendt LM, Kuperwasser C. Humanization of the Mouse Mammary Gland. In: Vivanco MDM, editor. Mammary Stem Cells. New York: Springer; 2015. pp. 173-86. [DOI: 10.1007/978-1-4939-2519-3_10] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
18 Lu Z, Zhan X, Wu Y, Cheng J, Shao W, Ni D, Han Z, Zhang J, Feng Q, Huang K. BrcaSeg: A Deep Learning Approach for Tissue Quantification and Genomic Correlations of Histopathological Images. Genomics Proteomics Bioinformatics 2021:S1672-0229(21)00152-2. [PMID: 34280546 DOI: 10.1016/j.gpb.2020.06.026] [Reference Citation Analysis]
19 DeFilippis RA, Chang H, Dumont N, Rabban JT, Chen YY, Fontenay GV, Berman HK, Gauthier ML, Zhao J, Hu D, Marx JJ, Tjoe JA, Ziv E, Febbraio M, Kerlikowske K, Parvin B, Tlsty TD. CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues. Cancer Discov 2012;2:826-39. [PMID: 22777768 DOI: 10.1158/2159-8290.CD-12-0107] [Cited by in Crossref: 110] [Cited by in F6Publishing: 81] [Article Influence: 11.0] [Reference Citation Analysis]
20 Gjorevski N, Nelson CM. Integrated morphodynamic signalling of the mammary gland. Nat Rev Mol Cell Biol 2011;12:581-93. [PMID: 21829222 DOI: 10.1038/nrm3168] [Cited by in Crossref: 137] [Cited by in F6Publishing: 126] [Article Influence: 12.5] [Reference Citation Analysis]
21 Wu A, Liao D, Tlsty TD, Sturm JC, Austin RH. Game theory in the death galaxy: interaction of cancer and stromal cells in tumour microenvironment. Interface Focus 2014;4:20140028. [PMID: 25097749 DOI: 10.1098/rsfs.2014.0028] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
22 Pinto MP, Dye WW, Jacobsen BM, Horwitz KB. Malignant stroma increases luminal breast cancer cell proliferation and angiogenesis through platelet-derived growth factor signaling. BMC Cancer 2014;14:735. [PMID: 25274034 DOI: 10.1186/1471-2407-14-735] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
23 Cuiffo BG, Karnoub AE. Mesenchymal stem cells in tumor development: emerging roles and concepts. Cell Adh Migr 2012;6:220-30. [PMID: 22863739 DOI: 10.4161/cam.20875] [Cited by in Crossref: 107] [Cited by in F6Publishing: 88] [Article Influence: 10.7] [Reference Citation Analysis]
24 Ruiz TFR, Taboga SR, Leonel ECR. Molecular mechanisms of mammary gland remodeling: A review of the homeostatic versus bisphenol a disrupted microenvironment. Reprod Toxicol 2021;105:1-16. [PMID: 34343637 DOI: 10.1016/j.reprotox.2021.07.011] [Reference Citation Analysis]
25 Andò S, Barone I, Giordano C, Bonofiglio D, Catalano S. The Multifaceted Mechanism of Leptin Signaling within Tumor Microenvironment in Driving Breast Cancer Growth and Progression. Front Oncol 2014;4:340. [PMID: 25505738 DOI: 10.3389/fonc.2014.00340] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Busch S, Rydén L, Stål O, Jirström K, Landberg G. Low ERK phosphorylation in cancer-associated fibroblasts is associated with tamoxifen resistance in pre-menopausal breast cancer. PLoS One 2012;7:e45669. [PMID: 23029174 DOI: 10.1371/journal.pone.0045669] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
27 Christopoulos PF, Corthay A, Koutsilieris M. Aiming for the Insulin-like Growth Factor-1 system in breast cancer therapeutics. Cancer Treat Rev 2018;63:79-95. [PMID: 29253837 DOI: 10.1016/j.ctrv.2017.11.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
28 Mazumdar S, Arendt LM, Phillips S, Sedic M, Kuperwasser C, Gill G. CoREST1 promotes tumor formation and tumor stroma interactions in a mouse model of breast cancer. PLoS One 2015;10:e0121281. [PMID: 25793264 DOI: 10.1371/journal.pone.0121281] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
29 Baslaim MM, Al-Amoudi SA, Ashoor AA. Unilateral breastfeeding: an unusual practice that might be the reason for future development of contralateral breast disease. Breastfeed Med 2011;6:131-5. [PMID: 21457081 DOI: 10.1089/bfm.2010.0083] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Pal A, Huang W, Li X, Toy KA, Nikolovska-Coleska Z, Kleer CG. CCN6 modulates BMP signaling via the Smad-independent TAK1/p38 pathway, acting to suppress metastasis of breast cancer. Cancer Res 2012;72:4818-28. [PMID: 22805309 DOI: 10.1158/0008-5472.CAN-12-0154] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
31 Eikesdal HP, Kalluri R. The Multifaceted Role of Cancer Associated Fibroblasts in Tumor Progression. In: Mueller MM, Fusenig NE, editors. Tumor-Associated Fibroblasts and their Matrix. Dordrecht: Springer Netherlands; 2011. pp. 361-80. [DOI: 10.1007/978-94-007-0659-0_19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
32 Al-Khalaf HH, Al-Harbi B, Al-Sayed A, Arafah M, Tulbah A, Jarman A, Al-Mohanna F, Aboussekhra A. Interleukin-8 Activates Breast Cancer-Associated Adipocytes and Promotes Their Angiogenesis- and Tumorigenesis-Promoting Effects. Mol Cell Biol 2019;39:e00332-18. [PMID: 30397072 DOI: 10.1128/MCB.00332-18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
33 Law AM, Lim E, Ormandy CJ, Gallego-Ortega D. The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy. Endocr Relat Cancer 2017;24:R123-44. [PMID: 28193698 DOI: 10.1530/ERC-16-0404] [Cited by in Crossref: 36] [Cited by in F6Publishing: 20] [Article Influence: 7.2] [Reference Citation Analysis]
34 Arendt LM. Modeling Breast Tumor Development with a Humanized Mouse Model. Methods Mol Biol 2016;1458:247-59. [PMID: 27581027 DOI: 10.1007/978-1-4939-3801-8_18] [Reference Citation Analysis]
35 Yang T, Xu F, Fang D, Chen Y. Targeted Proteomics Enables Simultaneous Quantification of Folate Receptor Isoforms and Potential Isoform-based Diagnosis in Breast Cancer. Sci Rep 2015;5:16733. [PMID: 26573433 DOI: 10.1038/srep16733] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
36 O'Leary KA, Shea MP, Schuler LA. Modeling prolactin actions in breast cancer in vivo: insights from the NRL-PRL mouse. Adv Exp Med Biol 2015;846:201-20. [PMID: 25472540 DOI: 10.1007/978-3-319-12114-7_9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
37 Gascard P, Tlsty TD. Carcinoma-associated fibroblasts: orchestrating the composition of malignancy. Genes Dev 2016;30:1002-19. [PMID: 27151975 DOI: 10.1101/gad.279737.116] [Cited by in Crossref: 331] [Cited by in F6Publishing: 324] [Article Influence: 66.2] [Reference Citation Analysis]
38 Sameni M, Cavallo-Medved D, Franco OE, Chalasani A, Ji K, Aggarwal N, Anbalagan A, Chen X, Mattingly RR, Hayward SW, Sloane BF. Pathomimetic avatars reveal divergent roles of microenvironment in invasive transition of ductal carcinoma in situ. Breast Cancer Res 2017;19:56. [PMID: 28506312 DOI: 10.1186/s13058-017-0847-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
39 Reddy LA, Mikesh L, Moskulak C, Harvey J, Sherman N, Zigrino P, Mauch C, Fox JW. Host response to human breast Invasive Ductal Carcinoma (IDC) as observed by changes in the stromal proteome. J Proteome Res 2014;13:4739-51. [PMID: 25244421 DOI: 10.1021/pr500620x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
40 Al-Rakan MA, Colak D, Hendrayani SF, Al-Bakheet A, Al-Mohanna FH, Kaya N, Al-Malik O, Aboussekhra A. Breast stromal fibroblasts from histologically normal surgical margins are pro-carcinogenic. J Pathol 2013;231:457-65. [PMID: 24009142 DOI: 10.1002/path.4256] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
41 Conklin MW, Eickhoff JC, Riching KM, Pehlke CA, Eliceiri KW, Provenzano PP, Friedl A, Keely PJ. Aligned collagen is a prognostic signature for survival in human breast carcinoma. Am J Pathol 2011;178:1221-32. [PMID: 21356373 DOI: 10.1016/j.ajpath.2010.11.076] [Cited by in Crossref: 664] [Cited by in F6Publishing: 626] [Article Influence: 60.4] [Reference Citation Analysis]
42 Katz E, Dubois-Marshall S, Sims AH, Gautier P, Caldwell H, Meehan RR, Harrison DJ. An in vitro model that recapitulates the epithelial to mesenchymal transition (EMT) in human breast cancer. PLoS One 2011;6:e17083. [PMID: 21347235 DOI: 10.1371/journal.pone.0017083] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
43 Barros da Silva P, Coelho M, Bidarra SJ, Neves SC, Barrias CC. Reshaping in vitro Models of Breast Tissue: Integration of Stromal and Parenchymal Compartments in 3D Printed Hydrogels. Front Bioeng Biotechnol 2020;8:494. [PMID: 32596217 DOI: 10.3389/fbioe.2020.00494] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
44 Pietilä M, Lehenkari P, Kuvaja P, Kaakinen M, Kaul SC, Wadhwa R, Uemura T. Mortalin antibody-conjugated quantum dot transfer from human mesenchymal stromal cells to breast cancer cells requires cell-cell interaction. Exp Cell Res 2013;319:2770-80. [PMID: 23928292 DOI: 10.1016/j.yexcr.2013.07.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
45 Furth PA. Cancer prevention as biomodulation: targeting the initiating stimulus and secondary adaptations. Ann N Y Acad Sci 2012;1271:1-9. [PMID: 23050958 DOI: 10.1111/j.1749-6632.2012.06736.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
46 Richardsen E, Uglehus RD, Johnsen SH, Busund LT. Immunohistochemical expression of epithelial and stromal immunomodulatory signalling molecules is a prognostic indicator in breast cancer. BMC Res Notes 2012;5:110. [PMID: 22353218 DOI: 10.1186/1756-0500-5-110] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
47 Salim MI, Supriyanto E, Haueisen J, Ariffin I, Ahmad AH, Rosidi B. Measurement of bioelectric and acoustic profile of breast tissue using hybrid magnetoacoustic method for cancer detection. Med Biol Eng Comput 2013;51:459-66. [PMID: 23238828 DOI: 10.1007/s11517-012-1014-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
48 Luo H, Yang G, Yu T, Luo S, Wu C, Sun Y, Liu M, Tu G. GPER-mediated proliferation and estradiol production in breast cancer-associated fibroblasts. Endocr Relat Cancer 2014;21:355-69. [PMID: 24481325 DOI: 10.1530/ERC-13-0237] [Cited by in Crossref: 46] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
49 Kuziel G, Thompson V, D'Amato JV, Arendt LM. Stromal CCL2 Signaling Promotes Mammary Tumor Fibrosis through Recruitment of Myeloid-Lineage Cells. Cancers (Basel) 2020;12:E2083. [PMID: 32731354 DOI: 10.3390/cancers12082083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
50 Rudnick JA, Arendt LM, Klebba I, Hinds JW, Iyer V, Gupta PB, Naber SP, Kuperwasser C. Functional heterogeneity of breast fibroblasts is defined by a prostaglandin secretory phenotype that promotes expansion of cancer-stem like cells. PLoS One 2011;6:e24605. [PMID: 21957456 DOI: 10.1371/journal.pone.0024605] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
51 Elkhattouti A, Hassan M, Gomez CR. Stromal Fibroblast in Age-Related Cancer: Role in Tumorigenesis and Potential as Novel Therapeutic Target. Front Oncol 2015;5:158. [PMID: 26284191 DOI: 10.3389/fonc.2015.00158] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
52 Mavrogonatou E, Papadopoulou A, Fotopoulou A, Tsimelis S, Bassiony H, Yiacoumettis AM, Panagiotou PN, Pratsinis H, Kletsas D. Down-Regulation of the Proteoglycan Decorin Fills in the Tumor-Promoting Phenotype of Ionizing Radiation-Induced Senescent Human Breast Stromal Fibroblasts. Cancers (Basel) 2021;13:1987. [PMID: 33924197 DOI: 10.3390/cancers13081987] [Reference Citation Analysis]
53 Giorello MB, Borzone FR, Labovsky V, Piccioni FV, Chasseing NA. Cancer-Associated Fibroblasts in the Breast Tumor Microenvironment. J Mammary Gland Biol Neoplasia 2021;26:135-55. [PMID: 33398516 DOI: 10.1007/s10911-020-09475-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
54 Locker J, Segall JE. Breast cancer: the matrix is the message. Am J Pathol 2011;178:966-8. [PMID: 21356348 DOI: 10.1016/j.ajpath.2010.12.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
55 Tossas-Milligan K, Shalabi S, Jones V, Keely PJ, Conklin MW, Eliceiri KW, Winn R, Sistrunk C, Geradts J, Miranda-Carboni G, Dietze EC, Yee LD, Seewaldt VL. Mammographic density: intersection of advocacy, science, and clinical practice. Curr Breast Cancer Rep 2019;11:100-10. [PMID: 33312342 DOI: 10.1007/s12609-019-00316-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Robertson C. The extracellular matrix in breast cancer predicts prognosis through composition, splicing, and crosslinking. Exp Cell Res 2016;343:73-81. [PMID: 26597760 DOI: 10.1016/j.yexcr.2015.11.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
57 Gomez CR. Role of heat shock proteins in aging and chronic inflammatory diseases. Geroscience 2021. [PMID: 34241808 DOI: 10.1007/s11357-021-00394-2] [Reference Citation Analysis]
58 Wei X, Li S, He J, Du H, Liu Y, Yu W, Hu H, Han L, Wang C, Li H, Shi X, Zhan M, Lu L, Yuan S, Sun L. Tumor-secreted PAI-1 promotes breast cancer metastasis via the induction of adipocyte-derived collagen remodeling. Cell Commun Signal 2019;17:58. [PMID: 31170987 DOI: 10.1186/s12964-019-0373-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
59 Majeed H, Okoro C, Kajdacsy-Balla A, Toussaint KC Jr, Popescu G. Quantifying collagen fiber orientation in breast cancer using quantitative phase imaging. J Biomed Opt 2017;22:46004. [PMID: 28388706 DOI: 10.1117/1.JBO.22.4.046004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
60 Alraouji NN, Hendrayani SF, Ghebeh H, Al-Mohanna FH, Aboussekhra A. Osteoprotegerin (OPG) mediates the anti-carcinogenic effects of normal breast fibroblasts and targets cancer stem cells through inhibition of the β-catenin pathway. Cancer Lett 2021;520:374-84. [PMID: 34416336 DOI: 10.1016/j.canlet.2021.08.013] [Reference Citation Analysis]
61 Rama-Esendagli D, Esendagli G, Yilmaz G, Guc D. Spheroid formation and invasion capacity are differentially influenced by co-cultures of fibroblast and macrophage cells in breast cancer. Mol Biol Rep 2014;41:2885-92. [PMID: 24469725 DOI: 10.1007/s11033-014-3144-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
62 Feng L, Huang S, An G, Wang G, Gu S, Zhao X. Identification of new cancer stem cell markers and signaling pathways in HER‑2‑positive breast cancer by transcriptome sequencing. Int J Oncol 2019;55:1003-18. [PMID: 31545416 DOI: 10.3892/ijo.2019.4876] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
63 Luo H, Liu M, Luo S, Yu T, Wu C, Yang G, Tu G. Dynamic monitoring of GPER-mediated estrogenic effects in breast cancer associated fibroblasts: An alternative role of estrogen in mammary carcinoma development. Steroids 2016;112:1-11. [PMID: 27016131 DOI: 10.1016/j.steroids.2016.03.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
64 Bahcecioglu G, Basara G, Ellis BW, Ren X, Zorlutuna P. Breast cancer models: Engineering the tumor microenvironment. Acta Biomater 2020;106:1-21. [PMID: 32045679 DOI: 10.1016/j.actbio.2020.02.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
65 Wang Y, Liang F, Zhou Y, Qiu J, Lv Q, Du Z. Sharp Downregulation of Hub Genes Associated With the Pathogenesis of Breast Cancer From Ductal Carcinoma In Situ to Invasive Ductal Carcinoma. Front Oncol 2021;11:634569. [PMID: 34094915 DOI: 10.3389/fonc.2021.634569] [Reference Citation Analysis]
66 Rauner G, Leviav A, Mavor E, Barash I. Development of Foreign Mammary Epithelial Morphology in the Stroma of Immunodeficient Mice. PLoS One 2013;8:e68637. [PMID: 23825700 DOI: 10.1371/journal.pone.0068637] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
67 Valdes C, Seo P, Tsinoremas N, Clarke J. Characteristics of cross-hybridization and cross-alignment of expression in pseudo-xenograft samples by RNA-Seq and microarrays. J Clin Bioinforma 2013;3:8. [PMID: 23594746 DOI: 10.1186/2043-9113-3-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
68 Salameh TS, Le TT, Nichols MB, Bauer E, Cheng J, Camarillo IG. An ex vivo co-culture model system to evaluate stromal-epithelial interactions in breast cancer. Int J Cancer 2013;132:288-96. [PMID: 22696278 DOI: 10.1002/ijc.27672] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
69 Jia W, Yang Z, Zhang X, Dong Y, Jia X, Zhou J. Shear wave elastography and pulsed doppler for breast lesions: Similar diagnostic performance and positively correlated stiffness and blood flow resistance. Eur J Radiol 2022;147:110149. [PMID: 35007981 DOI: 10.1016/j.ejrad.2021.110149] [Reference Citation Analysis]
70 Seewaldt VL. Cancer: Destiny from density. Nature 2012;490:490-1. [PMID: 23099400 DOI: 10.1038/490490a] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
71 Miroshnikova YA, Rozenberg GI, Cassereau L, Pickup M, Mouw JK, Ou G, Templeman KL, Hannachi EI, Gooch KJ, Sarang-Sieminski AL, García AJ, Weaver VM. α5β1-Integrin promotes tension-dependent mammary epithelial cell invasion by engaging the fibronectin synergy site. Mol Biol Cell 2017;28:2958-77. [PMID: 28877984 DOI: 10.1091/mbc.E17-02-0126] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
72 Sims AH, Larionov AA, Harrison DJ, Katz E. Use of microarray analysis to investigate EMT gene signatures. Methods Mol Biol 2013;1046:85-95. [PMID: 23868583 DOI: 10.1007/978-1-62703-538-5_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
73 Gallagher‐colombo SM, Finlay JC, Busch TM. Tumor Microenvironment as a Determinant of Photodynamic Therapy Resistance. In: Rapozzi V, Jori G, editors. Resistance to Photodynamic Therapy in Cancer. Cham: Springer International Publishing; 2015. pp. 65-97. [DOI: 10.1007/978-3-319-12730-9_3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
74 Huo CW, Chew G, Hill P, Huang D, Ingman W, Hodson L, Brown KA, Magenau A, Allam AH, McGhee E, Timpson P, Henderson MA, Thompson EW, Britt K. High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium. Breast Cancer Res 2015;17:79. [PMID: 26040322 DOI: 10.1186/s13058-015-0592-1] [Cited by in Crossref: 90] [Cited by in F6Publishing: 83] [Article Influence: 12.9] [Reference Citation Analysis]
75 Loftus PG, Watson L, Deedigan LM, Camarillo-Retamosa E, Dwyer RM, O'Flynn L, Alagesan S, Griffin M, O'Brien T, Kerin MJ, Elliman SJ, Barkley LR. Targeting stromal cell Syndecan-2 reduces breast tumour growth, metastasis and limits immune evasion. Int J Cancer 2021;148:1245-59. [PMID: 33152121 DOI: 10.1002/ijc.33383] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
76 Andò S, Barone I, Giordano C, Bonofiglio D, Catalano S. The Multifaceted Mechanism of Leptin Signaling within Tumor Microenvironment in Driving Breast Cancer Growth and Progression. Front Oncol 2014;4:340. [PMID: 25505738 DOI: 10.3389/fonc.2014.00340] [Cited by in Crossref: 14] [Cited by in F6Publishing: 38] [Article Influence: 1.8] [Reference Citation Analysis]
77 Boudreau A, van't Veer LJ, Bissell MJ. An "elite hacker": breast tumors exploit the normal microenvironment program to instruct their progression and biological diversity. Cell Adh Migr 2012;6:236-48. [PMID: 22863741 DOI: 10.4161/cam.20880] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
78 Giulianelli S, Herschkowitz JI, Patel V, Lamb CA, Gutkind JS, Molinolo A, Perou CM, Lanari C. MPA-induced gene expression and stromal and parenchymal gene expression profiles in luminal murine mammary carcinomas with different hormonal requirements. Breast Cancer Res Treat 2011;129:49-67. [DOI: 10.1007/s10549-010-1185-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]